Navigation Links
Global Human Vaccines Industry
Date:5/16/2012

apan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-168

Table 32: World Historic Review for Human Vaccines

(Prophylactic) by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) II-169

Table 33: World 15-Year Perspective for Human Vaccines(Prophylactic) by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World Markets forYears 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-170

Table 34: World Recent Past, Current & Future Analysis for

Human Vaccines (Prophylactic) by Product Segment - Pediatric

and Adult Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-171

Table 35: World Historic Review for Human Vaccines(Prophylactic) by Product Segment - Pediatric and AdultMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-172

Table 36: World 15-Year Perspective for Human Vaccines

(Prophylactic) by Product Segment - Percentage Breakdown of

Dollar Sales for Pediatric and Adult Markets for Years 2003,

2011 & 2017 (includes corresponding Graph/Chart) II-173

Table 37: World Recent Past, Current & Future Analysis forPediatric Prophylactic Vaccines by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... CARLSBAD, Calif. , May 23, 2013 Isis ... antisense therapeutics, today announced that management will present a company ... Health Care Conference on Thursday, May 30, 2013 at 8:40 ... A live audio webcast of the presentation will be ... Web site, www.isispharm.com .  A replay will be available ...
(Date:5/23/2013)... , May 23, 2013  Echo Pharma Acquisition ... to waive down the Acceptance Threshold from 90 percent ... one Elan Share in accordance with the terms of ... conditions summarized below. Under the terms of ... Elan (NYSE: ELN ) for $12.50 per ...
(Date:5/23/2013)... PARIS , May 23, 2013  Volcano Corporation ... manufacturer of precision guided therapy tools designed to enhance ... disease, today announced preliminary results from the ADVISE ( ... S tenosis E valuation) II trial during the ... 2013. These prospective results confirm prior retrospective publications, and ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
... , , , , , , ... MIVI-TRUST Phase III Program With Microplasmin Recruits a Total of Over,640 ... (Euronext Brussels: THR), a biopharmaceutical company,focused on the discovery and development ... that it has completed,the enrolment of the second Phase III trial ...
... , NORCROSS, Ga., Dec. 15 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that it will ... 6, 2010 after the market close. The Company will host ... a.m. (Eastern Time) to discuss the results. , ...
Cached Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4
(Date:5/23/2013)... members of the PETA International Science Consortium, Ltd., ... Safety Improvement Act of 2013: , Reform of ... also modernizes toxicity testing. , Ensuring the ... important goal. Reforming the EPA,s Toxic Substances ... the National Research Council,s vision for transforming toxicity ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... save an infant born with a serious airway malformation sheds ... and surgery. A report in the May 23 ... sparked the innovation. At first, the baby born five ... difficulty breathing and eating when he was 6 weeks old. ...
(Date:5/23/2013)... Located at 22343 La Palma Ave. #125, ... its Grand Opening Family Fun Charity event on May 11, ... and physical fitness. Sponsored by many different vendors like Chick-fil-a ... filled Grand Opening featured mini boot camp sessions and raffled ... the Yorba Linda fitness center has to offer. ...
(Date:5/23/2013)... 2013 Angeline Jolie’s brave decision to have ... was an 87% chance she would develop breast cancer is ... cancer. Long term studies show American women have a 12 ... , Among the things that can be changed to ... drink a day) smoking, and avoiding becoming obese. Choice of ...
(Date:5/23/2013)... TX (PRWEB) May 23, 2013 With rates ... people are searching for answers on how to lose weight. ... of going under the knife in an attempt to shed ... can be significantly outweighed by the negative health consequences that ... concern to consider before undergoing invasive surgery, colon cancer. ...
Breaking Medicine News(10 mins):Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer 2Health News:hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer 2Health News:hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer 3
... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... 2009 earnings on Monday, April 27, 2009. The Company will ... Time) on that date to discuss these results and other ...
... Ohio An experimental agent has shown promising results ... multi-institutional clinical trial led by cancer researchers at the ... AZD6244 (ARRY-142886), blocks certain enzymes that cancer cells need ... diagnosed with biliary cancer worldwide every year, representing 15-20 ...
... very difficult choices, such as deciding to end life-support for ... Journal of Consumer Research delves into the question of ... make those "tragic choices." , Authors Simona Botti (London ... University) say that from the time of Hippocrates until the ...
... vending machines offer healthy choices these days, so why do ... Journal of Consumer Research shows that some efforts ... have fulfilled a healthy eating goal even if they choose ... among food choices may draw their attention to the least-healthy ...
... WASHINGTON, April 20 Mark Leventhal, Esq., the Founder and ... first in the nation executive weight loss consulting service for ... Angeles County Bar Association, 1055 West 7th Street, 27th Floor, ... in 2009." Mark Leventhal will be talking about ...
... In an unprecedented effort to increase access to ... people with disabilities, President Obama invited CEOs from ... Tobin, United Spinal Association,s President ( www.unitedspinal.org ... briefing on the Administration,s disability policy initiatives, and ...
Cached Medicine News:Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 27, 2009 to Discuss First Quarter 2009 Results 2Health News:Targeted agent shows promise in biliary cancer study 2Health News:Tragic choices: Is it better for doctors or patient families to decide? 2Health News:Best intentions: The presence of healthy food can lead to unhealthy choices 2Health News:Mark Leventhal Speaks at the Los Angeles County Bar Association 2Health News:United Spinal Association Joins National Disability Leaders for Historic Meeting at the White House 2
The major innovation in posterior stabilized (PS) knee design. Improve patellofemoral kinematics. Reduce wear rate potential. Increase resistance to posterior tibial dislocation. Achieve at least 120...
... uni-compartmental knee replacement is an exciting development ... procedure provides patients with a minimally invasive ... the knee often results in severe pain, ... life and even depression. Orthopedic surgeons have ...
... total knee prosthesis stems from many years ... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern ... wear to a minimum. The inherent design ...
Cemented hip system...
Medicine Products: